Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependentAlice O. Kamphorst, Rafi Ahmed, Lydia Koenig et al.|Science|2017Cited by 1k
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patientsAlice O. Kamphorst, Suresh S. Ramalingam, Rathi N. Pillai et al.|Proceedings of the National Academy of Sciences|2017Cited by 899
Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case reportTaofeek K. Owonikoko, Suresh S. Ramalingam, Mukesh Kumar et al.|Cancer Immunology Immunotherapy|2016Cited by 59
Abstract 1317: Biomarker evaluation for PD-1 targeted therapies in non-small cell lung cancer (NSCLC) patientsAlice O. Kamphorst, Rafi Ahmed, Rathi N. Pillai et al.|Cancer Research|2015Cited by 1